Cancer Test Kit Market Analysis 2026

• The increasing prevalence of cancer is one of the major factors driving the market growth of cancer test kits:

The rise in cancer cases causes a significant impact globally. It accounts for the mortality rate across the globe and the growing technological markets encourage physicians to emphasize greatly on its treatment and prevention. As reported by World Health Organization (WHO), it is estimated that 10 million deaths have occurred globally in 2020. However, cancer mortality is higher in underdeveloped countries due to the late detection of the cancer stage and lack of access to treatments. According to GLOBACAN 2020, the number of cancer cases was estimated to rise to 37.5 million among the population. The biomarkers present in the cancer test kits allow the identification of genes, proteins, and antibodies in the sample, which indirectly tests the presence of cancer. Thus, the increasing prevalence of cancer and growing awareness of its early diagnosis and treatment increases the demand for the cancer test kit market. However, this growing awareness of cancer diagnostics integrated with technological advancements will further drive the market growth of cancer test kits.

Restraining factor

• The high cost associated with cancer test kits is a major factor restraining the market growth of the cancer test kit market.

Cancer test kits are used by patients at their homes. The screening is done according to their convenience. But these diagnostic test kits for cancer bear very high costs, which may deprive the patient to adopt such kits. The cost of cancer test kits ranges from USD 40 to USD 100. Moreover, patients can get a discount by placing a significant financial load on healthcare providers. According to the National Cancer Institute, the national economic impact of cancer-related costs was almost around USD 150 billion. Other factors responsible for hindering the market growth are false positive results from these test kits and issues related to accuracy. Therefore, all such factors contribute to impede the market growth of cancer test kits.

Impact of the COVID-19 Pandemic on the Cancer Test Kit Market:
The COVID-19 pandemic had significantly impacted the cancer test kit market. Rapidly spreading contagious infection had encouraged the population to use at-home solutions for the prevention of the risk of viral transmissions. The at-home test kits demand was increased rapidly due to their convenience and quick results. Similarly, the cancer test kits were patient-compatible and cost-effective and hence a substantial growth of its market was observed during the pandemic. Moreover, stool-based screening tests that patients perform at home, were overshadowed by colonoscopy and thereby its market got boosted. The hospitals postponed and only performed certain emergency procedures to preserve resources and prevent coronavirus transmission. During the pandemic, lockdowns and strict regulations were imposed on healthcare institutions and healthcare providers. Therefore, this resulted in a shift from hospital care to home care. There was seen decline in physician visiting and consultation which had given rise to the at home testing kits like cancer test kits. Thus, it was not necessary for patients to visit the hospital, or diagnostic centres for cancer testing.

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Cancer Test Kit Market is witnessing significant growth in the near future.

In 2023, the Blood Test segment accounted for noticeable share of global Cancer Test Kit Market and is projected to experience significant growth in the near future.

The Breast Cancer segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Abingdon Health , NanoEntek and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Frequently Asked Questions